Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-21-014320
Filing Date
2021-06-08
Accepted
2021-06-08 16:20:25
Documents
1
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1971
  Complete submission text file 0001437749-21-014320.txt   3557
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 1325 AVENUE OF AMERICAS, 28TH FLR. NEW YORK NY 10019
Business Address
Lindborg Stacy (Reporting) CIK: 0001813667 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15911 | Film No.: 211002394